NICE backs new treatment option for aggressive blood cancer
Digital Edition: NICE backs new treatment option for aggressive blood cancer
A new subcutaneous treatment option has been approved for use by the NHS in England and Wales for treating of an aggressive form of blood cancer.
You have read 1 of 1 free-access articles allowed for 30 - days. For further access please register or log in.
Subscribe for unlimited access.
- Over 6,000 peer-reviewed clinical articles
- Ask Nursing Times, use our new AI search engine service that exclusively reads Nursing Times and provides you with instant answers
- Online learning units on fundamental aspects of nursing care
- Bite-size learning through self-assessment and journal club
- A personal e-Portfolio to store and save CPD and revalidation evidence
- Nursing news and analysis and newsletters
- Discover nursing since 1905 and see how the profession has changed over the years
Register for guest access
- 1 week's unrestricted access to nursingtimes.net
- 3 free online learning units on fundamental aspects of nursing care
- Ask Nursing Times, use our new AI search engine service that exclusively reads Nursing Times and provides you with instant answers
- A personal e-Portfolio to store and save CPD and revalidation evidence
- Newsletters
Restricted to subscribers only - Discover nursing since 1905 and see how the profession has changed over the years
Already have an account, click here to sign in